Amlodipine Besylate Tablet
Product Images NDC 43063-764

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 43063-764). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063764 Label (43063764)

Label for AMLODIPINE BESYLATE USP 2.5 mg oral tablets from PD-Rx Pharmaceuticals, Inc. The label shows the product name with strength and dosage form, packing size of 30 tablets, and NDC 43063-764-30. It includes a warning to keep out of reach of children and storage instructions, reorder and lot numbers marked SAMPLE, and an expiration date of 01/50. The label has a green and black color scheme with barcodes and a QR code, manufactured by CPL Ltd in Verna, Goa, India.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01

Chemical structure diagram of amlodipine besylate, showing its molecular framework with labeled chemical groups and bonds. The formula C6H6O3S is noted alongside the structure.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02

A line graph showing event rates over 24 months comparing Amlodipine and placebo groups. The x-axis represents time in months, and the y-axis shows event rate. Two curves indicate lower event rates for Amlodipine versus placebo. Additional statistics include a P-value of 0.003, hazard ratio of 0.691, and 95% confidence interval from 0.54 to 0.88. The number of subjects at risk declines over time below the x-axis.*

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03

A forest plot showing hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus Placebo. Subgroups include Overall, Age groups (<65 and >=65), Gender, Baseline Sitting Systolic Blood Pressure (SBP), Baseline Vessel Disease, Baseline Vessels with Stenosis, and PCI-stent Strata. The x-axis represents hazard ratios ranging from 0.0 to 2.0, with a dashed vertical line at 1.0 indicating equal hazard between treatments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.